OpenHealth provides an API-driven platform that ingests raw laboratory results from any source and standardizes them into harmonized, AI-ready datasets, plus white-label visualization tools. The product is used by clinics, labs, health and wellness companies to deliver patient-friendly reports, longitudinal insights, and personalised care. The company says it is working toward building the world’s largest usable biomarker database with longitudinal data intended to improve the lives of over 100 million people. Customers include Latin America’s largest diagnostics and hospital groups, fitness and wellness companies such as Smart Fit, healthtech firms like Aware, and a growing network of longevity providers across Europe and the Americas. OpenHealth will use the new funding to accelerate expansion across Europe and to further develop its AI-powered technology for personalised prevention and care. The company is led by CEO and founder Gerrit Glass and is staffed by a European team with clinical, technical, and health system expertise. Financially, OpenHealth closed a $3M seed round and has raised $4.3M in total to date.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025